Company Filing History:
Years Active: 2016-2025
Title: Bo Jiang: Innovator in Eukaryotic Expression Systems
Introduction
Bo Jiang is a notable inventor based in Norwich, VT (US), recognized for his contributions to the field of biotechnology. He holds a total of 3 patents, focusing on advancements in eukaryotic expression systems and mutant fungal cells. His work has significant implications for the production of recombinant proteins and the enhancement of fermentation processes.
Latest Patents
One of Bo Jiang's latest patents is titled "Expression vectors for eukaryotic expression systems." This invention provides expression vectors designed for expressing recombinant proteins, such as biologics, in mammalian cells. The patent also includes host cells that comprise these expression vectors, along with methods for producing the recombinant proteins and propagating the expression vectors. Another significant patent is for "CRZ1 mutant fungal cells." This invention offers CRZ1 mutant fungal host cells that exhibit temperature resistance, enhanced fermentation robustness, and increased expression of heterologous polypeptides, including immunoglobulins. The methods for producing these heterologous polypeptides using the mutant fungal host cells are also covered in this patent.
Career Highlights
Bo Jiang is currently associated with Merck Sharp & Dohme Corp., where he continues to innovate and contribute to the field of biotechnology. His work is pivotal in developing new methods and systems that enhance the efficiency of protein production.
Collaborations
Some of Bo Jiang's notable coworkers include Jun Zhuang and Rebecca D Argyros, who collaborate with him on various projects within the company.
Conclusion
Bo Jiang's innovative work in eukaryotic expression systems and mutant fungal cells showcases his commitment to advancing biotechnology. His patents reflect a deep understanding of the complexities involved in protein production and fermentation processes.